Fortis’s Agilus challenge deepens
Forced to buy out investors of its struggling diagnostics arm, Fortis now has the additional burden of reviving Agilus even as it’s trying to get the core healthcare business back on track.
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
$99 for one year
Not ready to subscribe? Sign up for a free account
We value our free readers. Read 100+ stories every year.
More in Business
You may also like
The growing unease of EaseMyTrip’s investors
The online travel aggregator is struggling to grow now more than ever. Meanwhile, its promoters' stake sales reveal a pump and dump pattern that does little to ease shareholders’ concerns.
Milky Mist is a rare best-of-both-worlds business
IPO-bound Milky Mist is a dairy company that operates like an FMCG player. Its unique business model and ambitious promoter have served it well thus far. Now for the market test
Curefoods takes an old-school shot at a public listing
The Bengaluru-based startup has set its sights on an IPO all too quickly. A good mix of tech and services at a reasonable valuation might be its drawcard.